Investment Rating - The report maintains a "Buy" rating for the company, expecting a price increase of over 15% in the next 6-12 months [4]. Core Insights - The company reported a significant decline in profits for Q1 2025, with pre-tax and post-tax profits of 260 million and 190 million CNY, respectively, representing year-on-year decreases of 36.3% and 43.4% [2]. - The overseas compliance trend is improving, and the proprietary brand business is expected to continue performing well, driven by stricter regulations on illegal vaping products and market expansion [2][4]. - Increased marketing investments in proprietary brand business and rising stock incentive amortization and R&D expenses are impacting short-term profit performance, but the long-term outlook remains positive [3][4]. Financial Performance Summary - For 2025-2027, the expected EPS is 0.20, 0.40, and 0.56 CNY, with corresponding PE ratios of 46, 23, and 17 times [4]. - Revenue projections show a growth trajectory from 11,168 million CNY in 2023 to 19,489 million CNY by 2027, with a compound annual growth rate (CAGR) of approximately 20.45% [7]. - The net profit is expected to recover from 1,303 million CNY in 2024 to 3,451 million CNY in 2027, indicating a strong rebound in profitability [7].
思摩尔国际（06969）：港股公司点评：费用增多影响短期利润，HNB业务成长性值期待